Annual Working Capital
$14.06 M
-$18.14 M-56.34%
December 31, 2023
Summary
- As of February 8, 2025, KTTA annual working capital is $14.06 million, with the most recent change of -$18.14 million (-56.34%) on December 31, 2023.
- During the last 3 years, KTTA annual working capital has risen by +$13.82 million (+5723.61%).
- KTTA annual working capital is now -73.40% below its all-time high of $52.85 million, reached on December 31, 2021.
Performance
KTTA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$9.12 M
+$1.87 M+25.81%
September 30, 2024
Summary
- As of February 8, 2025, KTTA quarterly working capital is $9.12 million, with the most recent change of +$1.87 million (+25.81%) on September 30, 2024.
- Over the past year, KTTA quarterly working capital has increased by +$1.87 million (+25.81%).
- KTTA quarterly working capital is now -82.75% below its all-time high of $52.85 million, reached on December 31, 2021.
Performance
KTTA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
KTTA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -56.3% | +25.8% |
| 3 y3 years | +5723.6% | -78.8% |
| 5 y5 years | +5723.6% | -78.8% |
KTTA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -73.4% | at low | -82.8% | +25.8% |
| 5 y | 5-year | -73.4% | +5723.6% | -82.8% | +1839.7% |
| alltime | all time | -73.4% | +5723.6% | -82.8% | +1839.7% |
Pasithea Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.12 M(+25.8%) |
| Jun 2024 | - | $7.25 M(-32.4%) |
| Mar 2024 | - | $10.73 M(-23.7%) |
| Dec 2023 | $14.06 M(-56.3%) | $14.06 M(-24.9%) |
| Sep 2023 | - | $18.73 M(-27.4%) |
| Jun 2023 | - | $25.81 M(-11.0%) |
| Mar 2023 | - | $28.99 M(-10.0%) |
| Dec 2022 | $32.20 M | $32.20 M(-25.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $42.96 M(-9.9%) |
| Jun 2022 | - | $47.66 M(-5.6%) |
| Mar 2022 | - | $50.52 M(-4.4%) |
| Dec 2021 | $52.85 M(>+9900.0%) | $52.85 M(+157.7%) |
| Sep 2021 | - | $20.51 M(+4262.0%) |
| Jun 2021 | - | $470.10 K(-47.8%) |
| Mar 2021 | - | $900.60 K |
| Dec 2020 | $241.40 K | - |
FAQ
- What is Pasithea Therapeutics annual working capital?
- What is the all time high annual working capital for Pasithea Therapeutics?
- What is Pasithea Therapeutics annual working capital year-on-year change?
- What is Pasithea Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Pasithea Therapeutics?
- What is Pasithea Therapeutics quarterly working capital year-on-year change?
What is Pasithea Therapeutics annual working capital?
The current annual working capital of KTTA is $14.06 M
What is the all time high annual working capital for Pasithea Therapeutics?
Pasithea Therapeutics all-time high annual working capital is $52.85 M
What is Pasithea Therapeutics annual working capital year-on-year change?
Over the past year, KTTA annual working capital has changed by -$18.14 M (-56.34%)
What is Pasithea Therapeutics quarterly working capital?
The current quarterly working capital of KTTA is $9.12 M
What is the all time high quarterly working capital for Pasithea Therapeutics?
Pasithea Therapeutics all-time high quarterly working capital is $52.85 M
What is Pasithea Therapeutics quarterly working capital year-on-year change?
Over the past year, KTTA quarterly working capital has changed by +$1.87 M (+25.81%)